Rasagiline Mesylate: A Potent MAO-B Inhibitor for Parkinson's Disease Management
Discover the advanced therapeutic benefits of Rasagiline Mesylate, a key pharmaceutical intermediate vital for managing Parkinson's disease symptoms. As a leading supplier in China, we offer high-purity Rasagiline Mesylate to support your formulation needs.
Get a Quote & SampleAdvanced Parkinson's Treatment with Rasagiline Mesylate
Rasagiline Mesylate
As a reliable manufacturer and supplier of high-quality pharmaceutical intermediates, we provide Rasagiline Mesylate, a critical component in the treatment of Parkinson's disease. Our product, CAS 136236-51-6, is essential for improving patient outcomes by targeting dopamine levels in the brain.
- Potent MAO-B Inhibition: Leverage the power of Rasagiline Mesylate to effectively inhibit Monoamine Oxidase B, a key enzyme in dopamine metabolism.
- Effective Parkinson's Disease Therapy: Utilize this crucial pharmaceutical intermediate to formulate treatments that alleviate motor symptoms and improve quality of life for Parkinson's patients.
- High Purity & Stability: Trust our commitment as a leading supplier to provide consistently high-purity Rasagiline Mesylate, ensuring reliable efficacy in your formulations.
- Secure Supply Chain: As your trusted manufacturer in China, we guarantee a stable and dependable supply of Rasagiline Mesylate to meet your production demands.
Key Advantages of Sourcing Rasagiline Mesylate
Enhanced Dopamine Levels
Rasagiline Mesylate works by increasing dopamine availability in the brain, directly addressing the neurological deficit characteristic of Parkinson's disease. Explore how this advanced pharmaceutical intermediate can benefit your product development.
Reduced Motor Fluctuations
This MAO-B inhibitor is known to help manage motor fluctuations, enhancing 'on' time for patients. Partner with us, a premier rasagiline supplier, to access a product that delivers tangible therapeutic results.
Non-Amphetamine Metabolites
Unlike some predecessors, Rasagiline Mesylate does not metabolize into amphetamine derivatives, offering a favorable safety profile. Secure your supply of this advanced pharmaceutical intermediate from our reputable China-based manufacturing facility.
Applications of Rasagiline Mesylate
Parkinson's Disease Treatment
Primarily used as a monotherapy for early-stage Parkinson's or as an adjunct therapy for advanced stages, Rasagiline Mesylate is a cornerstone in managing motor symptoms. Investigate bulk purchase options from our manufacturer.
Neuroprotective Research
The R-enantiomer, central to Rasagiline Mesylate, exhibits significant potency and is explored for its neuroprotective properties, making it a valuable compound for ongoing research. Buy high-quality rasagiline intermediates for your R&D projects.
Pharmaceutical Formulations
As a critical pharmaceutical intermediate, Rasagiline Mesylate is formulated into oral tablets, requiring stringent quality control. Partner with us for a reliable source of this vital ingredient.
Neurological Disorder Therapies
Beyond Parkinson's, research explores the efficacy of MAO-B inhibitors like Rasagiline in other neurological conditions. Contact us for a quote on high-purity rasagiline for your research and development needs.